{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T15:00:20Z","timestamp":1788102020805,"version":"build-2803163510"},"reference-count":14,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vancomycin\u2010intermediate <jats:italic><jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>taphylococcus aureus<\/jats:italic> (<jats:styled-content style=\"fixed-case\">VISA<\/jats:styled-content>) infections are an emerging problem and antibiotic options are limited. We report the first case, to our knowledge, of heteroresistant <jats:styled-content style=\"fixed-case\">VISA<\/jats:styled-content> mediastinitis and bacteremia in a patient with a ventricular assist device who underwent orthotopic heart transplantation with clinical cure.<\/jats:p>","DOI":"10.1111\/tid.12123","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T04:47:30Z","timestamp":1375332450000},"source":"Crossref","is-referenced-by-count":13,"title":["Heart transplantation in a patient with heteroresistant vancomycin\u2010intermediate <i><scp>S<\/scp>taphylococcus aureus<\/i> ventricular assist device mediastinitis and bacteremia"],"prefix":"10.1111","volume":"15","author":[{"given":"T.H.","family":"Swartz","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases Department of Medicine Icahn School of Medicine at Mount Sinai New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Huprikar","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Department of Medicine Icahn School of Medicine at Mount Sinai New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"LaBombardi","sequence":"additional","affiliation":[{"name":"Department of Microbiology New York Hospital\u2010Queens Flushing New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pinney","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Anyanwu","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Department of Medicine Icahn School of Medicine at Mount Sinai New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Department of Medicine Icahn School of Medicine at Mount Sinai New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,8]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir034"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr066"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr234"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00857-10"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq113"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2012.00775.x"},{"key":"e_1_2_7_8_1","volume-title":"Clinical Laboratory and Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100\u2010S20","author":"CLSI","year":"2010"},{"key":"e_1_2_7_9_1","unstructured":"Theravance Inc.VIBATIV\u2122(televancin for injection) package insert 2008. Available athttp:\/\/www.vibativ.com."},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir935"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01128-10"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.1079-1082.2006"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902183400704"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl424"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00742-09"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftid.12123","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.12123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T08:36:16Z","timestamp":1695976576000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.12123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1111\/tid.12123"],"URL":"https:\/\/doi.org\/10.1111\/tid.12123","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}